Results: Of 48 patients, including 9 patients were used amikacin (18.8%), 36 patients were used colistin (75.0%), and 3 patients were used both colistin and amikacin (6.3%); 25 patients (52.1%) had developed AKI, 17 patients acquired at the first week and 8 patients acquired at the second week.